Zhang Xiaofan reports 0.6% stake in Yarrow Bioscience

Zhang Xiaofan filed Amendment No. 3 reporting beneficial ownership of common stock of Yarrow Bioscience, Inc..

Rhea-AI Filing Summary

Zhang Xiaofan filed Amendment No. 3 reporting beneficial ownership of common stock of Yarrow Bioscience, Inc.. The filing states beneficial ownership of 162,452 shares of common stock, representing 0.6% of the class. These shares are reported with both sole and shared voting and dispositive power.

Key Figures

Beneficially owned shares: 162,452 shares Percent of class: 0.6% Sole voting power: 162,452 shares +3 more

6 metrics

Beneficially owned shares 162,452 shares Amount beneficially owned by Zhang Xiaofan

Percent of class 0.6% Percentage of Yarrow Bioscience common stock class

Sole voting power 162,452 shares Shares over which Zhang Xiaofan has sole voting power

Shared voting power 162,452 shares Shares over which Zhang Xiaofan has shared voting power

Sole dispositive power 162,452 shares Shares over which Zhang Xiaofan has sole dispositive power

Shared dispositive power 162,452 shares Shares over which Zhang Xiaofan has shared dispositive power

Key Terms

beneficially owned, Sole Voting Power, Shared Voting Power, Sole Dispositive Power, +2 more

6 terms

beneficially owned financial

"Amount beneficially owned: 162452"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Sole Voting Power financial

"5 | Sole Voting Power 162,452.00"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

Shared Voting Power financial

"6 | Shared Voting Power 162,452.00"

Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

Sole Dispositive Power financial

"7 | Sole Dispositive Power 162,452.00"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

Shared Dispositive Power financial

"8 | Shared Dispositive Power 162,452.00"

par value financial

"common stock, par value $0.0001"

Par value is the fixed amount printed on a bond or stock that represents its original value when issued. It’s like the face value of a coin or bill—what the issuer promises to pay back or the starting price of a stock—though it often doesn’t change with market prices. It matters because it helps determine certain financial details, like how much the company will pay back at maturity.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What ownership stake in Yarrow Bioscience, Inc. (VYNE) does Zhang Xiaofan report?

Zhang Xiaofan reports beneficial ownership of 162,452 shares of Yarrow Bioscience, Inc. common stock, representing 0.6% of the class, according to Amendment No. 3 to the Schedule 13G.

What type of securities in Yarrow Bioscience, Inc. (VYNE) are covered in this Schedule 13G/A?

The filing covers common stock of Yarrow Bioscience, Inc., with a par value of $0.0001 per share, identified by CUSIP number 92941V407.

What voting and dispositive powers does Zhang Xiaofan report over VYNE shares?

Zhang Xiaofan reports 162,452 shares with sole voting power and 162,452 shares with shared voting power, and the same 162,452 shares for both sole and shared dispositive power.

Does Zhang Xiaofan own more than 5% of Yarrow Bioscience, Inc. (VYNE)?

No. The Schedule 13G/A explicitly states ownership of 5 percent or less of the class, with the reported beneficial ownership at 0.6% of Yarrow Bioscience, Inc.’s common stock.

What is the CUSIP and class title reported for Yarrow Bioscience, Inc. (VYNE)?

The class of securities is titled common stock, par value $0.0001 per share, and the CUSIP number disclosed is 92941V407.

When was this Amendment No. 3 to the Schedule 13G for VYNE signed?

The amendment was signed by Zhang Xiaofan on 08/13/2026, as indicated by the dated signature block in the Schedule 13G/A.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/13/2026 - 10:00 AM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 3)

Yarrow Bioscience, Inc.

(Name of Issuer)

common stock, par value $0.0001

(Title of Class of Securities)

92941V407

(CUSIP Number)

08/13/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 92941V407

1

Names of Reporting Persons

Zhang Xiaofan

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

HONG KONG

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 162,452.00
6	Shared Voting Power 162,452.00
7	Sole Dispositive Power 162,452.00
8	Shared Dispositive Power 162,452.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

162,452.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.6 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Yarrow Bioscience, Inc.
(b)	Address of issuer's principal executive offices: 470 JAMES STREET, SUITE 007, 470 JAMES STREET, SUITE 007, NEW HAVEN, CONNECTICUT, 06513.
Item 2.
(a)	Name of person filing: zhang xiaofan
(b)	Address or principal business office or, if none, residence: Rm1607, tower 3, 1038 Huashan Road, Shanghai, China
(c)	Citizenship: Hong Kong
(d)	Title of class of securities: common stock, par value $0.0001
(e)	CUSIP No.: 92941V407
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 162452
(b)	Percent of class: 0.6%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 162452
	(ii) Shared power to vote or to direct the vote: 162452
	(iii) Sole power to dispose or to direct the disposition of: 162452
	(iv) Shared power to dispose or to direct the disposition of: 162452
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Zhang Xiaofan

Signature:	Zhang Xiaofan
Name/Title:	Mr
Date:	08/13/2026